This CME-accredited blended activity is jointly provided by Rutgers Health, Rutgers Cancer Institute and RealCME in collaboration with RWJBarnabas Health

 

 

 

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by an educational grant from Regeneron Pharmaceuticals

 

TITLE

Community Deployment of Bispecific Antibodies in Multiple Myeloma & Non-Hodgkin Lymphoma within RWJBarnabas Health/Rutgers Cancer Institute

Release | Expiration: November 19, 2025 | November 19, 2026
 

OVERVIEW
This curriculum is designed to address the operational, clinical, and logistical challenges of integrating bispecific antibody (bsAb) therapies across the RWJBarnabas Health system. Building on established academic protocols, the program guides community clinicians in adapting workflows for safe bsAb administration, clarifying team roles, and strengthening coordination with academic hubs. Through evidence-based modules and practical implementation strategies, participants from each RWJBarnabas Health site will enhance their ability to select and sequence bsAbs appropriately, manage toxicities, and ensure continuity of care and equitable access for patients with multiple myeloma and non-Hodgkin lymphoma. The RWJBarnabas Health/Rutgers Cancer Institute consists of the following

NCI-designated Comprehensive Cancer Center

• Rutgers Cancer Institute/Robert Wood Johnson University Hospital New Brunswick (RWJUH)

 

Community-based Cancer Centers

• Clara Maass Medical Center
• Community Medical Center
• Cooperman Barnabas Medical Center
• Jersey City Medical Center
• Monmouth Medical Center
• Monmouth Medical Center Southern Campus
• Newark Beth Israel Medical Center
• Robert Wood Johnson University Hospital Hamilton
• Robert Wood Johnson University Hospital Rahway
• Robert Wood Johnson University Hospital Somerset
• Trinitas Regional Medical Center Elizabeth

 

FACULTY

	Mansi R. Shah, MD Clinical Director of Multiple Myeloma, Rutgers Cancer Institute; Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Disclosures	Mansi R. Shah, MD, has the following relevant disclosures. Consultant: Bristol Myers Squibb, Johnson & Johnson, Pfizer, Regeneron Pharmaceuticals; Grant/Research Support: AbbVie, Bristol Myers Squibb, Janssen Pharmaceutical, Regeneron Pharmaceuticals; Paid Speaker: Johnson & Johnson

 

	Matthew Matasar, MD Chief, Division of Blood Disorders, Rutgers Cancer Institute; Professor of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Disclosures	Matthew Matasar, MD, has the following relevant disclosures. Consultant: ADC Therapeutics, Allogene, Arvinas, AstraZeneca, Bristol Myer Squibb, Genentech, Genmab, Johnson & Johnson, Regeneron Pharmaceuticals, Roche; Expert Witness: Bayer

 

TARGET AUDIENCE
This activity is designed for hematologists/oncologists, hospitalists, ER and ICU staff, oncology nurses, nurse practitioners, physician associates, and pharmacists within academic and community oncology centers of RWJBarnabas Health/Rutgers Cancer Institute.
                                            

LEARNING OBJECTIVES

Upon completion of this activity, participants should be better able to:

• APPLY evidence-based strategies for patient selection and treatment sequencing of bsAbs in MM and NHL
• IMPLEMENT standardized protocols, define roles, and establish patient handoff and emergency procedures for bsAb administration at satellite clinics
• ASSESS infrastructure, staffing, and training needs to prepare satellite clinics for bsAb administration
• OPTIMIZE insurance navigation, reimbursement, and patient logistics
• DEVELOP long-term toxicity monitoring protocols and shared-care models to strengthen academic-community collaboration

 

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and RealCME. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

PHYSICIANS

Rutgers Biomedical and Health Sciences designates this other activity (blended live activity and enduring material) for a maximum of 4.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ADVANCED PRACTICE NURSES, NURSES, PHYSICIAN ASSOCIATES

AANP, ANCC, and NCCPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

 

PEER REVIEW
To help ensure content objectivity, independence, and fair balance and to ensure that the content is aligned with the interest of the public, this content has been reviewed by a non-conflicted, qualified reviewer.

This activity was peer-reviewed for relevance, accuracy of content, and balance of presentation by Ankit Shah, MD, Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School; Hematologist/Oncologist, Rutgers Cancer Institute, New Brunswick, NJ.

This activity was pilot-tested for time required for participation by Hematology/Oncology Fellows Meghana Subramanian, MD and Alexandra Noveihed, MD.

 

DISCLOSURE
In accordance with the disclosure policies of Rutgers Health and to conform with Joint Accreditation requirements and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any ineligible company, i.e., a company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients, within the past 24 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

 

REVIEWER

Ankit Shah, MD, has no relevant financial relationships with ineligible companies to disclose

 

FIELD TESTERS

Meghana Subramanian, MD and Alexandra Noveihed, MD, have no relevant financial relationships with ineligible companies to disclose

 

PLANNERS

The following planners have no relevant financial relationships with ineligible companies to disclose

 

RealCME

Erin Ash, MD, Medical Director

Krista Karch, PhD, Educational Facilitator

Erika Kunz, PharmD, Medical Writer

 

Rutgers Health Center for Continuing Outreach and Education

Patrick Dwyer, Director, Continuing Medical Education

 

UNAPPROVED PRODUCT USE

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration.  These disclosures are noted within the activity’s content.

 

DISCLAIMER

The views expressed in this activity are those of the faculty.  It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, Rutgers Health, or RealCME.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate.  However, participants are urged to consult all available data on products or procedures before using them in clinical practice.

Rutgers Health, and RealCME reserve the right to modify the activity content and faculty if necessary

 

METHOD OF PARTICIPATION/INSTRUCTIONS ON HOW TO RECEIVE CREDIT

There are no fees to participate in the activity. Participants are expected to review all activity information, including the learning objectives, disclosure statements, and participate in activity content (baseline and final self-assessments, three self-study modules, live group discussions, and group challenge scenarios and assignments).

To obtain credit, a score of 70% or better on the Final Assessment is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this curriculum, answered all test questions, completed the Final Assessment, Post Group Assessment, and evaluation, and have received a digital copy of your credit certificate.

Estimated time to complete this activity:  4.75 hours

• Baseline/Final Assessments: 30 minutes each for a total of up to 1.00 hour of CME
• Three (3) Self-Study Modules: 15 minutes each for a total of up to 0.75 hour of CME
• Two (2) Live Group Discussions: 45 minutes each for a total of up to 1.50 hour of CME
• Two (2) Group Challenges: 30 minutes each for a total of up to 1.00 hour of CME
• Action Plan (1) development: 30 minutes for a total of 0.50 hour of CME



If you are seeking credit, you must complete the assessment and evaluation at the conclusion of the activity. Your certificate can be printed immediately.
 

For questions regarding the activity content, or CE related questions or concerns, contact Rutgers Health at ccoe@ca.rutgers.edu

For technical questions related to this activity, please contact support@gathered.com.
 

PRIVACY STATEMENT
This website is managed by RealCME, and RealCME’s printed privacy policy applies to this site. CME credit for this activity is provided by Rutgers Health. If you register for CME credit for this educational activity, Rutgers Health will forward relevant personally identifiable information to Rutgers Health so that records can be maintained concerning any credits issued to you. Aggregated data concerning registrations, posttests, and evaluations may be shared, but RealCME will not knowingly share any personally identifiable information. Rutgers Health may use the information you provide on this site to contact you about your CME credit or other relevant educational activities provided through Rutgers Health.

To review the Rutgers Health CE privacy policy, click here.

Copyright © 2025. Rutgers Health and RealCME. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Rutgers Health and RealCME.